Ruxience (rituximab-pvvr)

**Product type:** Human Prescription Drug

**Active ingredient:** RITUXIMAB

**Strength:** 500 mg/50mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** Pfizer Laboratories Div Pfizer Inc

**Marketing category:** BLA (BLA761103)

**Pharmacologic class:** CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]